JP6251427B2 - Food composition for acquiring fish allergy resistance - Google Patents
Food composition for acquiring fish allergy resistance Download PDFInfo
- Publication number
- JP6251427B2 JP6251427B2 JP2017019076A JP2017019076A JP6251427B2 JP 6251427 B2 JP6251427 B2 JP 6251427B2 JP 2017019076 A JP2017019076 A JP 2017019076A JP 2017019076 A JP2017019076 A JP 2017019076A JP 6251427 B2 JP6251427 B2 JP 6251427B2
- Authority
- JP
- Japan
- Prior art keywords
- fish
- food composition
- product
- salmon
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013305 food Nutrition 0.000 title claims description 25
- 239000000203 mixture Substances 0.000 title claims description 24
- 206010016946 Food allergy Diseases 0.000 title description 22
- 201000005318 fish allergy Diseases 0.000 title description 17
- 241000251468 Actinopterygii Species 0.000 claims description 53
- 235000019688 fish Nutrition 0.000 claims description 51
- 102000004190 Enzymes Human genes 0.000 claims description 25
- 229940088598 enzyme Drugs 0.000 claims description 25
- 241000972773 Aulopiformes Species 0.000 claims description 24
- 108090000790 Enzymes Proteins 0.000 claims description 23
- 235000019515 salmon Nutrition 0.000 claims description 23
- 239000004365 Protease Substances 0.000 claims description 20
- 235000013372 meat Nutrition 0.000 claims description 19
- 206010020751 Hypersensitivity Diseases 0.000 claims description 18
- 241001282110 Pagrus major Species 0.000 claims description 14
- 108090000526 Papain Proteins 0.000 claims description 14
- 235000019834 papain Nutrition 0.000 claims description 14
- 229940055729 papain Drugs 0.000 claims description 14
- 102000035092 Neutral proteases Human genes 0.000 claims description 13
- 108091005507 Neutral proteases Proteins 0.000 claims description 13
- 241000277331 Salmonidae Species 0.000 claims description 12
- 230000007815 allergy Effects 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 10
- 208000026935 allergic disease Diseases 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 9
- 230000037396 body weight Effects 0.000 claims description 7
- 244000099147 Ananas comosus Species 0.000 claims description 5
- 235000007119 Ananas comosus Nutrition 0.000 claims description 5
- 108010004032 Bromelains Proteins 0.000 claims description 4
- 240000006432 Carica papaya Species 0.000 claims description 4
- 235000009467 Carica papaya Nutrition 0.000 claims description 4
- 235000019835 bromelain Nutrition 0.000 claims description 4
- 244000298697 Actinidia deliciosa Species 0.000 claims description 3
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 3
- 239000007857 degradation product Substances 0.000 description 26
- 230000000172 allergic effect Effects 0.000 description 22
- 208000010668 atopic eczema Diseases 0.000 description 22
- 239000000047 product Substances 0.000 description 19
- 238000012360 testing method Methods 0.000 description 16
- 239000013566 allergen Substances 0.000 description 13
- 108090000145 Bacillolysin Proteins 0.000 description 12
- 235000013399 edible fruits Nutrition 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 208000004262 Food Hypersensitivity Diseases 0.000 description 11
- 235000020932 food allergy Nutrition 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 241001504592 Trachurus trachurus Species 0.000 description 8
- 241000282412 Homo Species 0.000 description 7
- 208000030961 allergic reaction Diseases 0.000 description 6
- 230000002354 daily effect Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 235000013580 sausages Nutrition 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 235000013622 meat product Nutrition 0.000 description 5
- 230000009257 reactivity Effects 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 4
- 230000000593 degrading effect Effects 0.000 description 4
- 235000020883 elimination diet Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000009169 immunotherapy Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000277277 Oncorhynchus nerka Species 0.000 description 3
- 241000269821 Scombridae Species 0.000 description 3
- 235000008452 baby food Nutrition 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000020640 mackerel Nutrition 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 235000019512 sardine Nutrition 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 241000473391 Archosargus rhomboidalis Species 0.000 description 2
- 241000555825 Clupeidae Species 0.000 description 2
- 241000276438 Gadus morhua Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000277269 Oncorhynchus masou Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000001364 causal effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 230000003844 B-cell-activation Effects 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 102000009438 IgE Receptors Human genes 0.000 description 1
- 108010073816 IgE Receptors Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241000123826 Lutjanus campechanus Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 241000277329 Oncorhynchus keta Species 0.000 description 1
- 241000277338 Oncorhynchus kisutch Species 0.000 description 1
- 241000277275 Oncorhynchus mykiss Species 0.000 description 1
- 241001280377 Oncorhynchus tshawytscha Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 101710180012 Protease 7 Proteins 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 230000006044 T cell activation Effects 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000013568 food allergen Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000008944 intestinal immunity Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 108010043393 protease N Proteins 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- -1 stick Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
本発明は、ヒトなどにおいて、アレルギー耐性を獲得するための食品組成物等に関するものである。 The present invention relates to a food composition for acquiring allergy resistance in humans and the like.
現在では、日本人の3人に1人が何らかのアレルギーに羅患していると言われ、食物アレルギーに限れば、乳児で約10%、3歳児〜保育所児で約5%、学童以降で1.3〜2.6%程度がいると考えられている。なお、食物アレルギーとは、食物によって引き起こされる抗原特異的な免疫学的機序を介して生体にとって不利益な症状が惹起される現象をいう。 At present, it is said that one out of every three Japanese suffers from some kind of allergy. If it is limited to food allergies, it is about 10% for infants, about 5% for children aged 3 to 4, and after schoolchildren. It is considered that there is about 1.3 to 2.6%. In addition, food allergy refers to a phenomenon in which adverse symptoms are caused to the living body through an antigen-specific immunological mechanism caused by food.
食物アレルギーの原因物質(アレルゲン)は、卵、乳、小麦のいわゆる3大アレルゲンの他、ソバや落花生、甲殻類、魚類、果実類(バナナ、キウイ等)など多岐に渡り、そのアレルギー症状も蕁麻疹からアナフィラキシーまで様々である。なお、食物アレルギーの大部分は、即時型症状(原因食物摂取後、通常2時間以内にアレルギー反応が出現する症状)に分類される。 The allergens that cause food allergies range from so-called three major allergens such as eggs, milk, and wheat, as well as buckwheat, peanuts, crustaceans, fish, and fruits (bananas, kiwi, etc.). It varies from measles to anaphylaxis. The majority of food allergies are classified as immediate symptoms (symptoms in which an allergic reaction usually appears within 2 hours after ingestion of causal food).
食物アレルギーの予防・治療の基本は「原因食物の除去(除去食療法)」である。しかし、例えば魚類アレルギーでは、1魚種にアレルギー反応があると多くの魚種に対しても交差反応性でアレルギーをおこしてしまうことが多く、魚類アレルゲンに関する研究が不十分であることもあって、日本で食されている300〜400種の全ての魚介類及びその加工品を除去することが必要となる。 The basis of prevention and treatment of food allergy is “removal of causal food (elimination diet)”. However, for example, in fish allergies, if there is an allergic reaction in one fish species, many fish species are often cross-reactive and allergic, and research on fish allergens may be insufficient. It is necessary to remove all 300 to 400 kinds of seafood and processed products eaten in Japan.
また、食物アレルギーの治療法のひとつとして「経口免疫療法(少量のアレルゲン摂取による症状改善法)」もあるが、一般的に食物アレルギーは学童以降では耐性獲得の可能性が低く、また、魚類アレルギーの場合は寛容(耐性獲得)が得られにくいことが知られており(非特許文献1、2)、さらには、魚類アレルギーは閾値の極めて低い患者が多いこともあって、複数の魚種にアレルギー反応をおこす場合などの対応は現時点では除去食療法を行うしかない。 In addition, there is "oral immunotherapy (symptom amelioration method by taking a small amount of allergen)" as one of the treatment methods for food allergies. It is known that tolerance (acquisition of tolerance) is difficult to obtain in the case of (1), (2), and further, fish allergies are often caused by extremely low threshold patients. At present, the only way to deal with allergic reactions is to use an elimination diet.
しかしその一方で、アレルギー児を含む児童等にとって魚の摂取は、成長に欠かせないビタミンDや、EPA、DHAなどのn−3系多価不飽和脂肪酸の主要な供給源として重要である(非特許文献3)。また、日本人は動物性タンパク質の約40%を魚介類から摂取しているため、魚類はタンパク質の供給源としても重要な位置を占めている。この栄養源としての役割は、他の食物アレルゲン(卵、乳、小麦、大豆など)にも概ね同様のことが言える。したがって、除去食製造の負担軽減という目的も含め、食物アレルギー患者に対して除去食療法を用いないで治療等を行うことが患者の生活の質(QOL)向上等のために望ましい。 However, on the other hand, fish intake is important as a major source of vitamin D, n-3 polyunsaturated fatty acids such as EPA and DHA, which are indispensable for growth, for children including allergic children (non- Patent Document 3). In addition, because Japanese people consume about 40% of animal protein from seafood, fish occupy an important position as a protein source. This role as a nutrient source can be generally applied to other food allergens (eg, egg, milk, wheat, soybean). Therefore, for the purpose of improving the quality of life (QOL) of patients and the like, it is desirable to treat patients with food allergies without using the elimination diet, including the purpose of reducing the burden of producing the elimination diet.
このような技術背景の中、食物アレルギー患者、特に魚類アレルギー患者への経口免疫療法により、病状や症状を悪化させることなく、食物アレルギー耐性、特に複数の魚種へのアレルギー耐性を付与・獲得させ、食物アレルギー患者の生活の質(QOL)を向上させるための医薬剤等の開発が当業界において求められていた。 In such a technical background, oral allotherapy for food allergy patients, especially fish allergy patients, gives and acquires food allergy resistance, especially allergy resistance to multiple fish species, without exacerbating the pathology and symptoms. There has been a need in the art for the development of pharmaceutical agents and the like for improving the quality of life (QOL) of patients with food allergies.
本発明は、アレルギー症状(特に、魚類アレルギー症状)を誘発するヒトなどが、安全に且つ簡便にその耐性を獲得するための食品組成物等を提供することを目的とする。 An object of the present invention is to provide a food composition and the like for a human who induces allergic symptoms (particularly fish allergic symptoms) to acquire its resistance safely and easily.
上記目的を達成するため、本発明者らは鋭意研究の結果、サケ・マス類の魚肉を果実由来の中性プロテアーゼで分子量6,000以下に分解した魚肉酵素処理物を有効成分として、これを例えばヒトに対して1日当たり15〜40mg/kg体重の用量で3ヶ月間以上経口投与する方法等で用いることで、安全に且つ簡便にアレルギー耐性(特に、魚類アレルギー耐性)を獲得させることができることを見出し、本発明を完成するに至った。 In order to achieve the above object, as a result of intensive studies, the present inventors have used, as an active ingredient, a processed fish meat product obtained by decomposing salmon and trout fish meat with a neutral protease derived from fruits to a molecular weight of 6,000 or less. For example, allergic resistance (especially fish allergy resistance) can be acquired safely and simply by using it by oral administration to humans at a dose of 15 to 40 mg / kg body weight per day for 3 months or more. As a result, the present invention has been completed.
すなわち、本発明の実施形態は次のとおりである。
(1)サケ・マス類の魚肉(可食部)を果実由来の中性プロテアーゼで分子量6,000以下に分解した魚肉酵素処理物を有効成分とする魚類アレルギー耐性獲得用食品組成物。
(2)パパイヤ及び/又はパイナップル由来の中性プロテアーゼで処理した魚肉酵素処理物であることを特徴とする、(1)に記載の食品組成物。
(3)紅鮭の魚肉(可食部)を処理した魚肉酵素処理物であることを特徴とする、(1)又は(2)に記載の食品組成物。
(4)サケ・マス類の魚肉(可食部)を果実由来の中性プロテアーゼで分子量6,000以下に分解した魚肉酵素処理物を、1日当たり15〜40mg/kg体重で3ヶ月間以上経口投与することを特徴とする、魚類アレルギー耐性付与方法(ヒトに対する医療行為を除く)。
That is, the embodiment of the present invention is as follows.
(1) A food composition for acquiring fish allergy resistance, comprising as an active ingredient a fish enzyme treatment product obtained by degrading salmon and trout fish meat (edible part) to a molecular weight of 6,000 or less with a neutral protease derived from fruit.
(2) The food composition according to (1), which is a processed fish enzyme product treated with a neutral protease derived from papaya and / or pineapple.
(3) The food composition according to (1) or (2), which is a processed fish enzyme product obtained by processing fish meat (edible portion) of red sea bream.
(4) Salmon and trout fish meat (edible part) orally treated with fish-derived neutral protease to a molecular weight of 6,000 or less, orally at 15-40 mg / kg body weight per day for 3 months or more A method for imparting fish allergy resistance, which is characterized by administration (excluding medical practice for humans).
本発明によれば、サケ・マス類の魚肉を果実由来の中性プロテアーゼで分子量6,000以下に分解した魚肉酵素処理物を、例えば1日当たり15〜40mg/kg体重で3ヶ月間以上の用法・用量等で経口投与することにより、安全に(症状等を悪化させることなく)且つ簡便にアレルギー耐性(特に、多品種の魚類アレルギー耐性)獲得をさせることができる。そして、アレルギー患者への除去食提供が不要となり、アレルギー患者の生活の質(QOL)が向上するだけでなく、周囲の除去食製造負担等も軽減することができる。 According to the present invention, a processed fish meat product obtained by degrading salmon and trout fish meat with a neutral protease derived from fruits to a molecular weight of 6,000 or less is used, for example, at 15 to 40 mg / kg body weight per day for 3 months or more. -By oral administration at a dose, etc., allergy resistance (especially, all kinds of fish allergy resistance) can be acquired safely (without worsening symptoms and the like) and easily. And it becomes unnecessary to provide the removed food to the allergic patient, and not only the quality of life (QOL) of the allergic patient is improved, but also the burden of producing the removed removed food can be reduced.
本発明では、魚類アレルギー耐性獲得用食品組成物等の有効成分として、サケ・マス類の魚肉を果実由来の中性プロテアーゼで分子量6,000以下に分解した魚肉酵素処理物(魚肉酵素分解物)を使用する。 In the present invention, as an active ingredient for food composition for obtaining fish allergy resistance, salmon and trout fish meat is digested with a neutral protease derived from fruits to a molecular weight of 6,000 or less (fish meat enzyme degradation product). Is used.
このサケ・マス類の魚肉としては、サケ・マス類(科)サケ属に属するベニザケ(紅鮭)、シロザケ、マスノスケ(キングサーモン)、ギンザケ、カラフトマス、サクラマス、サツキマス、ニジマスなどの魚肉が例示され、特に、紅鮭の魚肉を用いることが好ましい。なお、ここで魚肉とは、魚から頭、骨、内臓などを除去して得られた(これらの若干の残存はありうる)可食部を意味する。特に、1尾分の魚肉を用いることが好ましい。 Examples of the salmon and trout fish include fish such as sockeye salmon (family) salmon belonging to the genus Salmon (red potato), chum salmon, salmon (king salmon), coho salmon, calaf trout, cherry salmon, salmon trout, rainbow trout, It is particularly preferable to use red salmon fish. Here, the fish meat means an edible portion obtained by removing the head, bones, internal organs and the like from the fish (there may be some of these remaining). In particular, it is preferable to use one fish meat.
また、使用する果実由来の中性プロテアーゼは、パパイヤ、パイナップル、キウイフルーツなどの果実から得られた、作用最適pHが中性域(例えばpH5〜8など)の食品用プロテアーゼであり、特に、パパイヤ及び/又はパイナップル由来の中性プロテアーゼを用いるのが好適である。これらは、果実から直接分離して得た精製品や粗精製品を使用しても良いし、市販品の使用も可能である。市販品としては、パパインW−40(パパイヤ由来,天野エンザイム株式会社製品)、ブロメラインF(パイナップル由来,天野エンザイム株式会社製品)などが例示される。 Further, the fruit-derived neutral protease used is a protease for foods obtained from fruits such as papaya, pineapple, kiwi fruit, etc. and having an optimum pH of action in a neutral range (for example, pH 5-8). It is also preferred to use a neutral protease derived from pineapple. These may be a purified product or a crude product obtained by directly separating from the fruit, or a commercially available product may be used. Examples of commercially available products include Papain W-40 (derived from papaya, product from Amano Enzyme Co., Ltd.), Bromelain F (derived from pineapple, product from Amano Enzyme Co., Ltd.), and the like.
魚肉の酵素分解処理は、例えば次のようにして行う。先ず、魚体可食部(頭、骨、内臓等を概ね除去した部分)を裁断、擂潰等によりミンチし、これに加水し、必要であればpH調整を行ってから酵素を0.5〜3%程度添加して、使用酵素の至適温度の前後で1〜5時間程度反応を行う。ここでは、魚肉酵素処理物の分子量を6,000以下とすることが重要であり、これより大きな分子が含まれることは好ましくない。また、分子をあまり小さく分解しすぎる(例えば全ての分子を分子量1,500未満とする)のもアレルギー耐性獲得効果の発揮という点で好ましくない。つまり、分子量6,000以下であり且つ1,500〜6,000の分子が一定程度含まれるように分解することが、単なる抗アレルギー効果ではなく、アレルギー耐性獲得効果の発揮という点で極めて重要である。 For example, the enzymatic decomposition of fish meat is performed as follows. First, the fish edible part (the part from which the head, bones, internal organs, etc. have been generally removed) is cut, minced by crushing, etc., added to this, adjusted to pH if necessary, and then the enzyme is added to 0.5 to Add about 3% and react for about 1 to 5 hours before and after the optimum temperature of the enzyme used. Here, it is important that the molecular weight of the fish meat enzyme-treated product is 6,000 or less, and it is not preferable that a larger molecule is contained. In addition, it is not preferable that the molecules are too small and decomposed too much (for example, all the molecules have a molecular weight of less than 1,500) from the standpoint of the effect of obtaining allergic resistance. In other words, it is extremely important to decompose so that the molecular weight is 6,000 or less and a certain amount of molecules of 1,500 to 6,000 is contained, from the standpoint of demonstrating allergic resistance acquisition effect, not just antiallergic effect. is there.
酵素処理後は、酵素失活処理(90〜98℃で15分程度)を行った後、必要に応じて不溶固形分除去処理(遠心分離、フィルター濾過)、殺菌処理などを行って粉末化する。粉末化は、スプレードライ、ドラムドライ、凍結乾燥などの定法により行うことができる。これにより、粉末剤形態の製剤を得ることができる。得られた魚肉酵素処理物粉末は、粗蛋白質80〜95%程度とすることが好ましいが、これに限定されるものではない。 After the enzyme treatment, an enzyme inactivation treatment (at 90 to 98 ° C. for about 15 minutes) is performed, and then an insoluble solid content removal treatment (centrifugation and filter filtration), a sterilization treatment, and the like are performed as necessary. . The pulverization can be performed by a conventional method such as spray drying, drum drying, or freeze drying. Thereby, the formulation of a powder form can be obtained. The obtained fish enzyme-treated powder is preferably about 80 to 95% of crude protein, but is not limited thereto.
本発明品の形態は、上記のような粉末剤のみならず、顆粒剤、錠剤、カプセル剤、散剤、スティック剤、液剤、ゲル剤、ペースト剤、シロップ剤などでも良く、経口投与可能な形態であれば特段の限定はない。そして、本発明品では、有効成分の効果を妨げない範囲で、賦形剤、結合剤、崩壊剤、滑沢剤、矯味矯臭剤、溶解補助剤、懸濁剤、コーティング剤などの医薬等の製剤技術分野において通常使用しうる既知の補助剤の1種又は2種以上を適宜組み合わせて配合した製剤とすることもできる。そして、形態、組成等を勘案し、原料の段階から製品が完成するまでの工程で本発明の有効成分と補助剤等を適宜配合して製造すればよい。 The form of the product of the present invention may be not only a powder as described above, but also a granule, tablet, capsule, powder, stick, liquid, gel, paste, syrup, etc. If there is no special limitation. And in the present invention products, such as excipients, binders, disintegrants, lubricants, flavoring agents, solubilizers, suspension agents, coating agents, etc. It can also be set as the formulation which mix | blended combining suitably the 1 type (s) or 2 or more types of the known adjuvant which can be normally used in the formulation technical field. Then, considering the form, composition, etc., the active ingredient of the present invention, adjuvants and the like may be appropriately blended and manufactured in the process from the raw material stage to the completion of the product.
本発明の魚類アレルギー耐性獲得用食品組成物等の用法ないし用量については、使用目的(予防、治療、又は保健の用途)、被検者の年齢、剤形等に応じて適宜定めればよく、例えば、15〜40mg/kg体重、好ましくは20〜30mg/kg体重の魚肉酵素処理物が、ヒトに対して3ヶ月間以上、好ましくは6ヶ月間以上、更に好ましくは10ヶ月間以上経口投与するようにするのが適当である。具体的には、体重33〜50kg程度のアレルギー児に対して1g/日で12ヶ月間毎日経口投与又は給与する方法など、が例示される。しかしながら、長期間に亘って保健上ないしは健康維持の目的などで摂取する場合などでは上記範囲よりも少量であってもよいし、また本有効成分は安全性についても問題がないので、上記範囲よりも多量で且つ長期間使用しても一向にさしつかえない。 The usage or dosage of the food composition for obtaining fish allergy resistance of the present invention may be appropriately determined according to the purpose of use (prophylaxis, treatment, or health use), the age of the subject, the dosage form, etc. For example, 15 to 40 mg / kg body weight, preferably 20 to 30 mg / kg body weight of fish enzyme-treated product is orally administered to humans for 3 months or more, preferably 6 months or more, more preferably 10 months or more. It is appropriate to do so. Specifically, a method of orally administering or feeding daily for 12 months at 1 g / day to an allergic child weighing about 33 to 50 kg is exemplified. However, in the case of ingestion for the purpose of health or maintenance of health over a long period of time, the amount may be smaller than the above range, and since this active ingredient has no safety problem, In large quantities, even if it is used for a long time, there is no problem.
なお、本発明は、サケ・マス類の魚肉を果実由来の中性プロテアーゼで分子量6,000以下に分解した魚肉酵素処理物を、健康補助食品、保健機能食品、サプリメント等の、特定の機能及び形態を有し、健康維持などを目的として摂取され、有効成分の用量(有効量)や用法が規定され且つ単位包装当たりでその用量が摂取できる、単に食品としてのみ利用されるものとは明確に区別される食品組成物(医薬部外品を含む)に含有させ、これをヒトに給与する方法を完全に除外するものではない。また、離乳期(母乳又は育児用ミルク等の乳汁栄養から幼児食に移行する過程)の乳幼児に与える離乳食に上記有効成分を含有させて給与することも同様であり、消化機能や腸管免疫機能が未発達の乳幼児への上記有効成分含有離乳食の給与はメリットとなり得る。 In the present invention, salmon and trout fish meat is processed with a fruit-derived neutral protease to a molecular weight of 6,000 or less, and the processed fish meat product has specific functions such as health supplements, health functional foods, supplements and the like. It is clear that it has a form, is ingested for the purpose of maintaining health, etc., and the dose (effective amount) and usage of the active ingredient is specified and can be ingested per unit package. It does not completely exclude the method of including it in differentiated food compositions (including quasi drugs) and feeding it to humans. The same applies to feeding baby food given to infants in the weaning period (the process of transition from breast nutrition such as breast milk or child-rearing milk to infant foods), and the digestive function and intestinal immunity function are the same. Feeding baby food containing the above active ingredients to undeveloped infants can be a merit.
そして、上述のような本発明によるアレルギー耐性獲得の評価方法としては、魚肉ソーセージを用いたアレルゲン負荷試験により行うのが好ましい。魚は、その部位(腹側、背側、頭側、尾側)によって1g当たりのアレルゲン量が大きく異なることが知られており、魚類アレルゲンの均一化及び評価結果の安定性という点において、上記魚肉ソーセージを用いたアレルゲン負荷試験が好適である。 And it is preferable to carry out by the allergen load test using a fish sausage as an evaluation method of acquisition of allergic resistance by the present invention as described above. It is known that the amount of allergen per gram varies greatly depending on the part (ventral side, dorsal side, head side, tail side) of fish, and in terms of homogenization of fish allergens and stability of evaluation results, An allergen challenge test using fish sausage is preferred.
魚肉ソーセージの調製方法としては、魚肉1尾分(可食部)を丸ごと裁断、擂潰等によりミンチし、これに食塩を添加・混合した後(荒擂り、塩擂りした後)成型し、必要であれば包装して、これを蒸すことにより得られる。このようにして得られた魚肉ソーセージは、魚類アレルゲンが全体に均一に分散していることが特徴である。 As a method for preparing fish sausage, cut one whole fish (edible portion), mince it by crushing, crushing, etc., adding salt to it and mixing (after roughening and salting), then molding If so, it can be obtained by packaging and steaming it. The fish sausage thus obtained is characterized in that the fish allergen is uniformly dispersed throughout.
なお、本発明のうち、サケ・マス類の魚肉を果実由来の中性プロテアーゼで分子量6,000以下に分解した魚肉酵素処理物をヒトに経口投与又は給与するアレルギー耐性付与方法に係る発明については、ヒトに対する医療行為(医師等による患者への医療行為)が除外される。 Of the present invention, the invention relating to the allergy resistance imparting method for orally administering or feeding to humans a processed fish meat product obtained by degrading salmon and trout fish meat with a neutral protease derived from fruit to a molecular weight of 6,000 or less , Medical practice for humans (medical practice for patients by doctors, etc.) is excluded.
このようにして、サケ・マス類の魚肉を果実由来の中性プロテアーゼで分子量6,000以下に分解した魚肉酵素処理物を有効成分としてなる魚類アレルギー耐性獲得用食品組成物等を使用し、これをアレルギー患者に経口免疫療法等で用いることで、安全に且つ簡便にアレルギー耐性(特に、多品種の魚類アレルギー耐性)を獲得させることが可能となる。 In this way, a food composition for obtaining fish allergy resistance and the like, comprising as an active ingredient a fish enzyme-treated product obtained by decomposing salmon and trout fish meat with a neutral protease derived from fruit to a molecular weight of 6,000 or less, is used. Can be used for oral immunotherapy or the like for allergic patients, and it is possible to safely and easily acquire allergic resistance (particularly, all kinds of fish allergy resistance).
食物アレルギーに代表される即時型アレルギーの発症は、低分子化されていないペプチド(概ね20〜50アミノ酸(分子量は約2,000〜6,000))が腸管から吸収され、抗原提示細胞(マクロファージ等)に取り込まれると、T細胞の活性化、B細胞の活性化(アレルゲン特異的IgE抗体産生)、肥満細胞上のIgE受容体への抗体結合が逐次的に行われ、アレルゲンがこの特異的IgE抗体に結合することで、ヒスタミン等の化学伝達物質が放出され、アレルギー反応が誘発される。 In the onset of immediate allergy represented by food allergy, peptides that are not reduced in molecular weight (generally 20 to 50 amino acids (molecular weight is about 2,000 to 6,000)) are absorbed from the intestine and antigen-presenting cells (macrophages). Etc.), T cell activation, B cell activation (allergen-specific IgE antibody production), and antibody binding to IgE receptors on mast cells are sequentially performed, and the allergen is specifically detected. By binding to the IgE antibody, a chemical mediator such as histamine is released, and an allergic reaction is induced.
本発明の魚類アレルギー耐性獲得用食品組成物等は、魚肉の適度な酵素分解により、T細胞との反応性は残したままで且つ特異的IgE抗体との反応性をゼロ(又はほぼゼロ)としており、これによってアレルギー耐性を獲得させていることが特徴である。 The food composition for acquiring fish allergy resistance of the present invention has zero (or almost zero) reactivity with a specific IgE antibody while maintaining the reactivity with T cells by the appropriate enzymatic degradation of fish meat. This is characterized by acquiring allergic resistance.
以下、本発明の実施例について述べるが、本発明はこれらの実施例のみに限定されるものではなく、本発明の技術的思想内においてこれらの様々な変形が可能である。 Examples of the present invention will be described below, but the present invention is not limited to these examples, and various modifications can be made within the technical idea of the present invention.
(魚類アレルギー耐性獲得用食品組成物等の製造)
以下の方法で、本発明品である魚類アレルギー耐性獲得用食品組成物を含む魚肉酵素処理物(魚肉酵素分解物)を製造した。
(Manufacture of food compositions for acquiring fish allergy resistance)
By the following method, a fish enzyme processed product (fish enzyme degradation product) containing the food composition for acquiring fish allergy resistance as the product of the present invention was produced.
紅鮭(可食部)1尾分をミンチ処理したものに、その重量に対して100%の水と1%の各種プロテアーゼ(下記表1に記載)を添加し、それぞれの酵素の至適温度付近(主に50℃前後)で各3時間攪拌した。その後、95℃15分間の加熱処理により酵素を失活させ、遠心分離操作(1,400×g、10分間)により可溶化していないタンパク質を除去し、上清を回収した。これを、珪藻土濾過(液量に対して1%添加)により微粒子を除去し、その後、フィルター濾過(0.45μm)、殺菌(90℃、10分間)を行ってからスプレードライヤーで粉末化した。 100% water and 1% various proteases (listed in Table 1 below) are added to minced bean paste (edible portion) and the vicinity of the optimum temperature of each enzyme (Mainly around 50 ° C.) and stirred for 3 hours each. Thereafter, the enzyme was inactivated by heat treatment at 95 ° C. for 15 minutes, the protein not solubilized was removed by centrifugation (1,400 × g, 10 minutes), and the supernatant was recovered. Fine particles were removed from this by filtration through diatomaceous earth (added 1% with respect to the liquid volume), and then filtered (0.45 μm) and sterilized (90 ° C., 10 minutes), and then powdered with a spray dryer.
(アレルゲン性評価試験)
実施例1で作製した各種酵素分解物のアレルゲン性を評価確認するため、以下の試験を実施した。
(Allergenicity evaluation test)
In order to evaluate and confirm the allergenicity of various enzyme degradation products prepared in Example 1, the following tests were performed.
鮭にアレルギー反応を示す患者(2名)の血清中の特異的IgE抗体を用い、これと各種酵素分解物の反応性をELISAテストにより確認した。その結果、紅鮭魚肉パパインW−40分解物及び紅鮭魚肉ブロメラインF分解物は特異的IgE抗体との反応性が完全に消失していること、他の分解物は反応性が残存していることが明らかとなった(図1)。 Using specific IgE antibodies in the sera of patients (2 persons) who had an allergic reaction to sputum, the reactivity of this and various enzyme degradation products was confirmed by ELISA test. As a result, the red sea bream fish papain W-40 degradation product and the red sea bream fish bromelain F degradation product have completely lost the reactivity with the specific IgE antibody, and the other degradation products remain reactive. It became clear (Fig. 1).
なお、このうち紅鮭魚肉パパインW−40分解物の分析値及びHPLC(高速液体クロマトグラフィー)溶出データを表2、図2に示した。なお、HPLCの条件は、カラムとしてShodex Asahipak GS−320 7G(φ7.6mm×500mm)、オーブン温度は設定なし(室温)、移動相は0.1%TFAを含む45%アセトニトリル溶液、流速は1.0mL/min、測定波長は220nmで行った。この結果、当該分解物の分子量は6,000以下となっていること、及び、分子量1,500〜6,000の分子が一定程度含まれていることが明らかとなった。 Of these, the analytical values and HPLC (high performance liquid chromatography) elution data of red sea bream papain W-40 degradation products are shown in Table 2 and FIG. The HPLC conditions were as follows: Shodex Asahipak GS-320 7G (φ7.6 mm × 500 mm) as column, oven temperature not set (room temperature), mobile phase 45% acetonitrile solution containing 0.1% TFA, flow rate 1 0.0 mL / min, and the measurement wavelength was 220 nm. As a result, it became clear that the molecular weight of the decomposition product was 6,000 or less and that molecules having a molecular weight of 1,500 to 6,000 were contained to a certain extent.
(経口免疫療法評価確認試験)
実施例1で作製した紅鮭魚肉パパインW−40分解物を用いて、アレルギー患者への経口免疫療法を行った場合の評価確認をするため、以下の試験を実施した。
(Oral immunotherapy evaluation confirmation test)
In order to confirm the evaluation when oral immunotherapy for allergic patients was performed using the red sea bream fish papain W-40 degradation product prepared in Example 1, the following test was performed.
鮭、マグロ、アジなど複数の魚にアレルギーを示す、蕁麻疹や頻回の嘔吐などアナフィラキシー歴を有する11歳女児(体重約38kg)を被験者とし、まず、プリック試験で紅鮭魚肉パパインW−40分解物(1gが魚肉1gに相当)に対してアレルギー反応がないことを確認した。 A 11-year-old girl with a history of anaphylaxis such as urticaria and frequent vomiting (weight approximately 38 kg), who is allergic to multiple fish such as sea bream, tuna, horse mackerel, etc., was first tested in a prick test. It was confirmed that there was no allergic reaction to the product (1 g corresponds to 1 g of fish meat).
これとは別に、3枚におろした紅鮭(1尾分)又はアジ(1尾分)をミンチ処理し、荒擂り及び塩擂り(食塩添加量は魚肉重量に対して1.0%)を行った後成型し、蒸し工程(95℃4分間→90〜95℃6分間の計10分間)で処理して得られた魚肉ソーセージを摂取させ、鮭又はアジアレルゲン負荷試験を行った。この被験者は、鮭ソーセージの積算量が0.3gで口唇に膨疹が出現し、アジソーセージは積算量1.3gで上口唇に紅斑2個が出現した。 Separately, minced red sea bream (one fish) or horse mackerel (one fish) on 3 sheets, and then roughed and salted (salt added 1.0% of fish weight) Then, the fish sausage obtained by molding and steaming (95 ° C. for 4 minutes → 90 to 95 ° C. for 6 minutes in total for 10 minutes) was ingested, and a salmon or Asian allergen load test was performed. In this test subject, wheal appeared on the lips when the cumulative amount of salmon sausage was 0.3 g, and two erythema appeared on the upper lip when the cumulative amount was 1.3 g.
その後、紅鮭魚肉パパインW−40分解物を1g/日の用量で連日摂取させ、3ヶ月後、6ヶ月後、10ヶ月後に同一の負荷試験を実施した。その結果、紅鮭魚肉パパインW−40分解物摂取前においては、鮭で0.3g、アジで1.3gの負荷でアレルギー症状が誘発されていたのに対し、紅鮭魚肉パパインW−40分解物の連日摂取により、6ヶ月後には鮭で6.3g(積算量)、10ヶ月後には鮭、アジともに20g(積算量)摂取可能となり、アレルギー症状は全く誘発されず、これらのアレルギー耐性を獲得していることが明らかとなった(図3)。つまり、紅鮭魚肉パパインW−40分解物の連日投与によって、安全に摂取可能な鮭の量を約66倍に、アジの量を約15倍に増加させることができた。 Then, red sea bream fish papain W-40 degradation product was ingested daily at a dose of 1 g / day, and the same stress test was performed after 3 months, 6 months and 10 months. As a result, allergic symptoms were induced with a load of 0.3 g of salmon and 1.3 g of horse mackerel before ingestion of red sea bream fish papain W-40 degradation product, whereas red sea bream fish papain W-40 degradation product By daily intake, 6.3g (cumulative amount) of salmon after 6 months and 20g (cumulative amount) of both salmon and horse mackerel can be consumed after 10 months, and allergic symptoms are not induced at all. (Fig. 3). That is, by daily administration of red sea bream fish papain W-40 degradation product, it was possible to increase the amount of salmon that can be safely ingested by about 66 times and the amount of horse mackerel by about 15 times.
さらには、鮭、アジ、タラ、マグロ、サバ、イワシの特異的IgE抗体価及び総IgE値の推移も確認したところ、総IgE値は上昇しているのにもかかわらず、各魚種に対する特異的IgE抗体価は、試験開始6ヶ月後から低下していることが明らかとなった(図4)。つまり、紅鮭魚肉パパインW−40分解物の連日投与によって、鮭だけでなくアジ、タラ、マグロ、サバ、イワシなどの耐性も獲得することができることが示された。 Furthermore, when changes in specific IgE antibody titers and total IgE values of salmon, horse mackerel, cod, tuna, mackerel, and sardines were also confirmed, the specific IgE values increased despite the increase in total IgE values. It was clarified that the target IgE antibody titer decreased from 6 months after the start of the test (FIG. 4). That is, it was shown that resistance to not only sea bream, horse mackerel, cod, tuna, mackerel, sardine, etc. can be acquired by daily administration of red sea bream fish papain W-40 degradation product.
なお、紅鮭魚肉パパインW−40分解物を当該試験の用量(1g/日)で毎日1年間食べ続けても、副作用やアレルギー反応等は全くなく、安全に継続摂取出来ることも確認された。 In addition, it was confirmed that even if the red sea bream fish papain W-40 degradation product was continuously eaten for 1 year every day at the dose (1 g / day), there was no side effect or allergic reaction, and it could be safely and continuously ingested.
以上より、本発明品の一例である紅鮭魚肉パパインW−40分解物を少量ずつ毎日アレルギー患者に経口投与することで、安全且つ簡便に、鮭アレルギーだけでなく、各種魚類(アジ、タラ、マグロ、サバ、イワシ等)アレルギーに対しての耐性を獲得させることができるということが明らかとなった。 As described above, the red snapper fish papain W-40 degradation product, which is an example of the present invention, is orally administered daily to allergic patients in small amounts to ensure not only allergic allergies but also various fish (aji, cod, tuna) It was revealed that tolerance to allergies can be acquired.
本発明を要約すれば、以下の通りである。 The present invention is summarized as follows.
本発明は、魚類アレルギー症状を誘発するヒトなどが、安全に且つ簡便にその耐性を獲得するための食品組成物等を提供することを目的とする。 An object of the present invention is to provide a food composition or the like for a human who induces fish allergy symptoms to acquire its tolerance safely and easily.
そして、サケ・マス類(特に、紅鮭)の魚肉(可食部)を果実由来の中性プロテアーゼで分子量6,000以下に分解した魚肉酵素処理物を有効成分として、これを例えばヒトに対して1日当たり15〜40mg/kg体重の用量で3ヶ月間以上経口投与する方法等で用いることで、安全に且つ簡便に魚類アレルギー耐性を獲得させることができる。 And the processed fish meat product obtained by degrading salmon and trout (especially red salmon) fish meat (edible part) with a neutral protease derived from fruit to a molecular weight of 6,000 or less is used as an active ingredient. Fish allergy resistance can be acquired safely and simply by using it by oral administration for 3 months or more at a dose of 15 to 40 mg / kg body weight per day.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017019076A JP6251427B2 (en) | 2017-02-03 | 2017-02-03 | Food composition for acquiring fish allergy resistance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017019076A JP6251427B2 (en) | 2017-02-03 | 2017-02-03 | Food composition for acquiring fish allergy resistance |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013081523A Division JP6207863B2 (en) | 2013-04-09 | 2013-04-09 | Allergy resistance acquisition agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017075189A JP2017075189A (en) | 2017-04-20 |
| JP6251427B2 true JP6251427B2 (en) | 2017-12-20 |
Family
ID=58549943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017019076A Active JP6251427B2 (en) | 2017-02-03 | 2017-02-03 | Food composition for acquiring fish allergy resistance |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6251427B2 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2764276B2 (en) * | 1988-09-06 | 1998-06-11 | 仙味エキス株式会社 | Functional novel peptides and their use |
| JP2001328945A (en) * | 2000-05-19 | 2001-11-27 | Hidehiko Yokogoshi | Allergic reaction protective agent |
| JP2008208097A (en) * | 2007-02-28 | 2008-09-11 | Marutomo Co Ltd | Hard-to-digest protein for mitigating allergic symptom |
-
2017
- 2017-02-03 JP JP2017019076A patent/JP6251427B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017075189A (en) | 2017-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6306197B2 (en) | Animal protein hydrolyzate, production method thereof and use thereof | |
| JP5749419B2 (en) | Muscle enhancer | |
| JP4901950B2 (en) | Acidic food and drink containing 2,5-piperazinedione, 3,6-bis (phenylmethyl)-, (3S, 6S)- | |
| KR20130014532A (en) | Agent for preventing muscular atrophy | |
| JP6207545B2 (en) | Learning and memory capacity enhancer | |
| JP6697245B2 (en) | Endurance improver | |
| Lin et al. | Hypocholesterolemic effect of compounded freshwater clam protein hydrolysate and Gracilaria | |
| Chung et al. | Reducing food allergy: is there promise for food applications? | |
| US10716322B1 (en) | Oral/enteral vegetarian food compositions and method of manufacturing the same | |
| JP6251427B2 (en) | Food composition for acquiring fish allergy resistance | |
| JP6368390B2 (en) | Evaluation method for acquiring fish allergy resistance | |
| JP6207863B2 (en) | Allergy resistance acquisition agent | |
| JP2001046021A (en) | Materials for enhancing physical strength and recovering from fatigue and foods using the same | |
| JP2001057869A (en) | Material for ameliorating obesity and dieting, and diet food | |
| CN100544617C (en) | A clinical enteral nutrition agent for marine organisms | |
| CN107691760A (en) | A kind of oyster peptide of enhancing development and its preparation method and application | |
| JP4673071B2 (en) | Iron-adsorptive polymer substance, iron-containing polymer substance, and production method thereof | |
| RU2824902C2 (en) | Oral or enteral food compositions and methods for their preparation | |
| RU2806689C2 (en) | Oral or enteral food compositions and methods for their production | |
| JP6279851B2 (en) | Muscle atrophy prevention and / or muscle synthesis promoter | |
| JP2019092502A (en) | Separation method of nondenaturing water-soluble component of egg material, device therefor, and drink and food composite | |
| RU2366263C2 (en) | Broth with preventive properties, containing protein hydrolisate and protein hydrolisate production method | |
| JP2001057868A (en) | Lipid metabolism-improving material and food using the same | |
| EA046949B1 (en) | ORAL OR ENTERAL FOOD COMPOSITIONS AND METHOD FOR THEIR PRODUCTION | |
| JP2007228875A (en) | Anti-fatigue peptide derived from meat protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170228 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20171010 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171031 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171121 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171124 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6251427 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |